Cannabis Report
Home > Boards > US OTC > Biotechs >

OncoVista Innovative Therapies, Inc. (OVIT)

OVIT RSS Feed
Add OVIT Price Alert      Hide Sticky   Hide Intro
Moderator: sharkgroupsn, gi197845
Search This Board: 
Last Post: 7/2/2018 10:54:32 AM - Followers: 22 - Board type: Free - Posts Today: 0

OncoVista Innovative Therapies, Inc. (OVIT) 

 

Please see the bottom of the iBox for a contrary view on this stock.

 

http://www.oncovista.com/

 

 

Company Information:

OncoVista Innovative Therapies, Inc.
14785 Omicron Drive
Suite 104
San Antonio,, TX 78245

Phone: 210-677-6000

 

CIK:  0001094847

The latest 10Q can be found here: http://filings.issuerdirect.com/data/1094847/000114420411063209/v240119_10q.pdf

Link to clinical trials register: http://www.clinicaltrials.gov/ct2/results?term=cordycepin 

Neither of the two cordycepin studies registered with clinical.trials.gov has been updated for over two years, which is a breach of registration conditions.

 

 

OncoVista Innovative Therapies, Inc., is a bio-pharmaceutical company that claims to be dedicated to providing innovative, safe and efficacious treatments for cancer through the use of biomarkers in order to extend and improve the quality of life for patients.

Based in San Antonio, Texas, OncoVista was incorporated in 2004 and says it utilizes state-of-the-art drug discovery technologies, innovative clinical development and registration strategies as well as emerging technologies to bring to market new, safe and highly effective anti-cancer drugs. Although no such drugs have yet been brought to market, and the "incubator" behind Onco Vista, Technology Innovations, LLC, has a long and inglorious history of transferring monies from its publicly held spin-offs such as Biophan and Natural Nano into private hands.

 

Management: 

http://www.oncovista.com/index.php?option=com_content&task=view&id=67

 

 

Claims made by Onco Vista regarding its Core Capabilities for Accelerated Drug Development

Lipitek International
Well-equipped research labs for chemical synthesis and biological evaluations; GMP manufacturing suite

UT Health Science Center (Prof. Luduena)
Biological evaluation and testing of new anti-mitotics, including tubulin isotype-specific assays

University of Alberta (Prof. Tuszynski)
Molecular modeling, computer simulation of new molecules, molecule design and in silico screening

AAI Oncology (Paris)
Global oncology-focused clinical Contract Research Organization (CRO)

Cancer Therapy & Research Center (CTRC)/Institute for Drug Development (IDD)
In vitro and in vivo capabilities; Phase I/II clinical trials

Other Local Resources (nothing to do with Onco Vista per se: probably included here to give an impression of referred respectability).
Southwest Oncology Group
Southwest Foundation for Biomedical Research

 

 

 

Press Releases:  
http://www.oncovista.com/index.php?option=com_content&task=view&id=91

http://finance.yahoo.com/q/h?s=OVIT.OB+Headlines

 

 

-----------------------

 

 

 

AdnaGen

http://www.adnagen.com/

 

News from AdnaGen site, which is majority owned by OVIT

http://www.adnagen.com/HTML_Dateien/e_news_news.htm

 

OVIT used to own 78% of the issued and outstanding shares of AdnaGen*

 

* On November 2, 2010, OncoVista Innovative Therapies, Inc. (the "Company") entered into a Stock Purchase Agreement with Alere Holdings Bermuda Limited Canon's Court ("Alere Holdings"), whereby the Company sold all of its shares, representing approximately 78.01% of the total issued and outstanding shares, of its majority-owned German operating subsidiary AdnaGen AG ("AdnaGen").   Under the terms of the Stock Purchase Agreement, the Company and the other AdnaGen shareholders agreed to sell their respective shares of AdnaGen, and all AdnaGen related business assets, to Alere Holdings in consideration of: (i) a $10,000,000 up-front;  (ii) $10,000,000 in potential milestone payments contingent upon the achievement of various balance sheet objectives within 24 months; and (iii) up to $63,000,000 in potential milestone payments contingent upon the achievement of various clinical, regulatory and sales objectives within 36 months (collectively, the "Consideration").  The Company is entitled to receive its pro rata portion of approximately 78.01% of all Consideration.http://www.sec.gov/Archives/edgar/data/1094847/000114420410057309/v200923_8k.htm

 

----------------------

  

Filings:

http://www.sec.gov/cgi-bin/browse-edgar?company=&match=&CIK=0001094847&filenum=&State=&Country=&SIC=&owner=exclude&Find=Find+Companies&action=getcompany

 

Share Structure:

Authorized Shares

147,397,390 as of September 30, 2011

 

Outstanding Shares

21,370,725 as of September 30, 2011

 

Investor Relations:

Aimee Boutcher

973-239-2878

aboutcher@aol.com

 

 

 


 

 


 

 

 

 

All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.

 


 

Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp

 

Cannabis Report
OVIT
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts
No plusone'd posts yet. Be the first!
PostSubject
#500   Haven't heard, I dropped out this stock months sharkey1 07/02/18 10:54:32 AM
#499   any update om merger or Dr Weis health biotech2 07/01/18 10:13:35 AM
#498   All true, expect the part about me buying. biotech2 06/28/18 09:29:26 AM
#497   Re: biotech2; The reason for the new, 52 gi197845 06/21/18 01:33:14 PM
#496   new yearly high, wonder why ? biotech2 06/21/18 07:33:46 AM
#495   biotech2 06/20/18 07:20:31 PM
#494   I wish that were true, but is not............... biotech2 06/19/18 08:23:04 AM
#493   No need for a reverse shell merger, into gi197845 06/18/18 11:28:13 AM
#492   Re: biotech2; Ok man, that sounds like a gi197845 06/14/18 09:09:55 AM
#491   I own 80,000 shares of XXII that I biotech2 06/13/18 01:52:56 PM
#490   Re: Ok, thanks bitoech2, since you've been right gi197845 06/13/18 09:12:43 AM
#489   no, but it will before Labor Day................. biotech2 06/13/18 09:04:27 AM
#488   Is it happening tomorrow? gi197845 06/12/18 08:24:54 PM
#487   I would expect something similar executed sharkgroupsn 06/12/18 08:20:01 AM
#486   2007 BigWorm129 06/12/18 12:00:52 AM
#485   OncoVista Innovative Therapies Inc., merger news. gi197845 06/11/18 11:03:32 PM
#484   It could be http://kezarlifesciences.com. Etrade posted they went gi197845 06/11/18 06:20:36 PM
#483   Tomorrow works for me. For this to turn Batermere 06/11/18 03:25:44 AM
#482   I'll be scanning the newswire in the morning. BigWorm129 06/10/18 11:53:27 PM
#481   Thanks Buddy! Stallion4life38 06/08/18 11:25:17 AM
#480   TIME TO BUY OVIT SHARES !!!!!!!!!!! biotech2 06/08/18 08:35:21 AM
#479   Soon as in any day now. sharkgroupsn 06/08/18 06:21:20 AM
#478   When you say soon, how soon you talking Stallion4life38 06/07/18 02:02:16 PM
#477   Great! Thanks buddy! Stallion4life38 06/07/18 01:57:58 PM
#476   Yes there is. And soon. sharkgroupsn 06/07/18 01:51:14 PM
#475   Is there a potential merger here? Stallion4life38 06/07/18 01:13:17 PM
#474   wasn't that previous Weis deal done at $3.50 biotech2 06/07/18 08:23:07 AM
#473   coreect, we do not know what the initial biotech2 06/07/18 08:11:12 AM
#472   Anyone have any clue on who it might BigWorm129 06/07/18 08:03:44 AM
#471   It will. These guys own too many shares. sharkgroupsn 06/07/18 07:57:03 AM
#470   Thanks. I hope it happens. I’ve been pummeled Batermere 06/07/18 06:36:05 AM
#469   Weis did the same type of merger in sharkgroupsn 06/07/18 05:31:43 AM
#468   IMO there will be another bio w promising sharkgroupsn 06/07/18 05:24:26 AM
#467   Really close to what, shark? And if you Batermere 06/06/18 11:36:07 PM
#466   There appears to have been lots of buying gi197845 06/06/18 08:13:05 PM
#465   Moderate volume again today. I think we’re really close. sharkgroupsn 06/06/18 07:56:29 PM
#464   I bet they are working on one right biotech2 06/05/18 07:39:10 AM
#463   Get it together Dr.Weis, daughter and investment firms, gi197845 06/03/18 03:40:09 PM
#462   “several dollars in a couple of years” will Batermere 05/28/18 11:31:16 PM
#461   I agree with initial stock price going up biotech2 05/28/18 10:30:02 PM
#460   Wow. That would get my losses back and Batermere 05/28/18 09:18:15 PM
#459   One would think in the ongoing talks with sharkgroupsn 05/28/18 07:58:39 PM
#458   sharky: Any idea where the SP could end Batermere 05/28/18 07:41:53 PM
#457   Based on conversations recently I’d assume reverse merger. sharkgroupsn 05/28/18 07:31:25 PM
#456   Any idea what the END GAME will be, shark? Batermere 05/28/18 07:02:46 PM
#455   New buyers will start coming in soon sharkgroupsn 05/28/18 06:51:28 PM
#454   Anything is better than nothing, gi. I’d given Batermere 05/28/18 05:27:20 PM
#453   Thanks, I hope we at least make some gi197845 05/28/18 02:48:53 PM
#452   I also hold a sizable position. Would consider sharkgroupsn 05/26/18 09:28:33 PM
#451   Welcome back, gi. Between INNV and OVIT, I Batermere 05/26/18 07:14:58 PM
PostSubject